BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30377796)

  • 21. Histopathological evidence of neoplastic progression of von Meyenburg complex to intrahepatic cholangiocarcinoma.
    Bhalla A; Mann SA; Chen S; Cummings OW; Lin J
    Hum Pathol; 2017 Sep; 67():217-224. PubMed ID: 28823571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD44 Expression Is a Prognostic Factor in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection.
    Morine Y; Imura S; Ikemoto T; Iwahashi S; Saito YU; Shimada M
    Anticancer Res; 2017 Oct; 37(10):5701-5705. PubMed ID: 28982889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Immunohistochemical Analysis of Osteopontin and S100 Calcium-binding Protein P is Useful for Subclassifying Large- and Small-duct Type Intrahepatic Cholangiocarcinomas.
    Yoshizawa T; Uehara T; Iwaya M; Nakajima T; Shimizu A; Kubota K; Notake T; Kitagawa N; Masuo H; Sakai H; Hayashi H; Tomida H; Yamazaki S; Hirano S; Ota H; Soejima Y
    Am J Surg Pathol; 2024 Jun; 48(6):751-760. PubMed ID: 38584480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma.
    Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Srinontong P; Ratasuwan P; Narong K; Nielsen PS; Maekawa Y
    Int J Cancer; 2016 Jan; 138(2):396-408. PubMed ID: 26312563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis.
    Gong ZJ; Cheng JW; Gao PT; Huang A; Sun YF; Zhou KQ; Hu B; Qiu SJ; Zhou J; Fan J; Yang XR
    Oncologist; 2019 Jul; 24(7):997-1007. PubMed ID: 30910867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma.
    Lok T; Chen L; Lin F; Wang HL
    Hum Pathol; 2014 Feb; 45(2):394-400. PubMed ID: 24439226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.
    Tsai JH; Huang WC; Kuo KT; Yuan RH; Chen YL; Jeng YM
    Histopathology; 2012 Dec; 61(6):1106-16. PubMed ID: 22882148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial cell adhesion molecule is a prognosis marker for intrahepatic cholangiocarcinoma.
    Sulpice L; Rayar M; Turlin B; Boucher E; Bellaud P; Desille M; Meunier B; Clément B; Boudjema K; Coulouarn C
    J Surg Res; 2014 Nov; 192(1):117-23. PubMed ID: 24909871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome.
    Yang XW; Li L; Hou GJ; Yan XZ; Xu QG; Chen L; Zhang BH; Shen F
    Oncotarget; 2017 Jan; 8(5):7710-7721. PubMed ID: 28032598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-level clonal FGFR2 amplification defines a unique molecular subtype of intrahepatic cholangiocarcinoma in a Chinese population.
    Pu XH; Ye Q; Yang J; Wu HY; Ding XW; Shi J; Mao L; Fan XS; Chen J; Qiu YD; Huang Q
    Hum Pathol; 2018 Jun; 76():100-109. PubMed ID: 29514108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma.
    Zhang XF; Dong M; Pan YH; Chen JN; Huang XQ; Jin Y; Shao CK
    Hum Pathol; 2017 Jul; 65():92-100. PubMed ID: 28457731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma.
    Ahn CS; Hwang S; Lee YJ; Kim KH; Moon DB; Ha TY; Song GW; Lee SG
    ANZ J Surg; 2018 Mar; 88(3):212-217. PubMed ID: 27598539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection.
    Huang C; Tian Y; Peng R; Zhang C; Wang D; Han S; Jiao C; Wang X; Zhang H; Wang Y; Li X
    J Gastroenterol Hepatol; 2015 Feb; 30(2):421-33. PubMed ID: 25168293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes following resection of intrahepatic cholangiocarcinoma.
    Tabrizian P; Jibara G; Hechtman JF; Franssen B; Labow DM; Schwartz ME; Thung SN; Sarpel U
    HPB (Oxford); 2015 Apr; 17(4):344-51. PubMed ID: 25395176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and Prognosis.
    Chen Y; Hong Z; Lu S; Zhang N; Rong G; Chang X; Liu Z; Bai W; Dong Z; Gao X; Zeng Z; Lu Y
    Med Sci Monit; 2018 Nov; 24():7875-7882. PubMed ID: 30390420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection.
    Jing CY; Fu YP; Shen HJ; Zheng SS; Lin JJ; Yi Y; Huang JL; Xu X; Zhang J; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
    Oncotarget; 2017 Feb; 8(8):13293-13303. PubMed ID: 28076328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct Clinicopathologic and Genetic Features of 2 Histologic Subtypes of Intrahepatic Cholangiocarcinoma.
    Hayashi A; Misumi K; Shibahara J; Arita J; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M
    Am J Surg Pathol; 2016 Aug; 40(8):1021-30. PubMed ID: 27259014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
    Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
    World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence.
    Chan KM; Tsai CY; Yeh CN; Yeh TS; Lee WC; Jan YY; Chen MF
    BMC Gastroenterol; 2018 Dec; 18(1):180. PubMed ID: 30514231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.